CPT code 11901 denotes an intralesional corticosteroid injection, commonly used to treat large nodules, keloids, lichenified hyperkeratotic lesions, and related cutaneous conditions. The code captures a focused, lesion-targeted therapeutic procedure delivered by dermatology, plastic surgery, or other outpatient procedural specialties. Nationally, this code matters because it is commonly used in outpatient dermatologic and procedural care for scar modulation and inflammatory lesion control, with implications for coverage policies, prior authorization workflows, and coding accuracy.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for the procedure and typical sites of service, alongside benchmarks and policy considerations relevant to payer coverage and billing practice. The publication provides guidance on appropriate documentation elements, common billing scenarios, and potential areas of payer scrutiny. This summary serves clinicians, coding staff, and policy analysts seeking a concise reference to the clinical purpose and billing implications of CPT code 11901 in the outpatient procedural setting.